Tom Lüdde

777 total citations
21 papers, 268 citations indexed

About

Tom Lüdde is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Tom Lüdde has authored 21 papers receiving a total of 268 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 7 papers in Hepatology and 6 papers in Surgery. Recurrent topics in Tom Lüdde's work include Liver Disease Diagnosis and Treatment (6 papers), Liver physiology and pathology (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). Tom Lüdde is often cited by papers focused on Liver Disease Diagnosis and Treatment (6 papers), Liver physiology and pathology (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). Tom Lüdde collaborates with scholars based in Germany, Netherlands and Austria. Tom Lüdde's co-authors include Christian Trautwein, Ulrike Assmus, Tania Roskams, Sara Vander Borght, Naiara Beraza, Twan Lammers, Felix Heymann, Matthias Bartneck, Uwe Gbureck and Frank Tacke and has published in prestigious journals such as Journal of Clinical Oncology, ACS Nano and Gastroenterology.

In The Last Decade

Tom Lüdde

19 papers receiving 264 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tom Lüdde Germany 5 75 73 64 56 45 21 268
Maria F. Leite Brazil 7 73 1.0× 111 1.5× 72 1.1× 123 2.2× 24 0.5× 9 351
Lei Dou China 12 54 0.7× 123 1.7× 55 0.9× 115 2.1× 26 0.6× 18 395
Yaowei Bai China 10 154 2.1× 40 0.5× 105 1.6× 20 0.4× 21 0.5× 44 296
Chen Shen China 7 47 0.6× 136 1.9× 47 0.7× 15 0.3× 28 0.6× 27 292
Zhongqi Fan China 10 29 0.4× 74 1.0× 76 1.2× 18 0.3× 25 0.6× 25 261
Jessica Brownell United States 7 85 1.1× 84 1.2× 95 1.5× 100 1.8× 41 0.9× 8 327
Zuojin Liu China 8 44 0.6× 132 1.8× 39 0.6× 75 1.3× 13 0.3× 17 326
Flaviana Cau Italy 12 22 0.3× 84 1.2× 27 0.4× 25 0.4× 21 0.5× 29 331
Feng Shen China 13 114 1.5× 88 1.2× 193 3.0× 12 0.2× 38 0.8× 27 391
Änne Schmitz Germany 11 74 1.0× 57 0.8× 51 0.8× 22 0.4× 30 0.7× 24 380

Countries citing papers authored by Tom Lüdde

Since Specialization
Citations

This map shows the geographic impact of Tom Lüdde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Lüdde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Lüdde more than expected).

Fields of papers citing papers by Tom Lüdde

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom Lüdde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Lüdde. The network helps show where Tom Lüdde may publish in the future.

Co-authorship network of co-authors of Tom Lüdde

This figure shows the co-authorship network connecting the top 25 collaborators of Tom Lüdde. A scholar is included among the top collaborators of Tom Lüdde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tom Lüdde. Tom Lüdde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
González-Carmona, Maria A., Marie‐Luise Berres, Dominik Paul Modest, et al.. (2025). First results of an open-label, single arm phase II trial investigating the efficacy and safety of trifluridine/tipiracil combined with irinotecan as a second line therapy in patients with cholangiocarcinoma.. Journal of Clinical Oncology. 43(16_suppl). 4121–4121.
2.
Groiss, Stefan Jun, Torsten Feldt, Björn‐Erik Ole Jensen, et al.. (2024). The population based cognitive testing in subjects with SARS-CoV-2 (POPCOV2) study: longitudinal investigation of remote cognitive and fatigue screening in PCR-positive cases and negative controls. Frontiers in Human Neuroscience. 18. 1468204–1468204. 1 indexed citations
3.
4.
Buescher, Gustav, Kornelius Schulze, Marianne Sinn, et al.. (2024). 157P Soluble and EV-bound CD27 act as antagonistic biomarkers in patients with solid tumors undergoing immunotherapy. Annals of Oncology. 35. S277–S278. 1 indexed citations
5.
May, Petra, et al.. (2023). Incidence of hepatic adenomas in adult glycogen storage disease type Ia/b. Zeitschrift für Gastroenterologie. 61(1). e28–e28.
6.
Ghallab, Ahmed, Ute Hofmann, Maiju Myllys, et al.. (2023). Inhibition of the renal apical sodium-dependent bile acid transporter prevents cholemic nephropathy. Journal of Hepatology. 78. S940–S941. 3 indexed citations
7.
Amygdalos, Iakovos, Felix Schmidt, Jan Bednarsch, et al.. (2023). Survival after combined resection and ablation is not inferior to that after resection alone, in patients with four or more colorectal liver metastases. Langenbeck s Archives of Surgery. 408(1). 343–343. 4 indexed citations
8.
Pfeuffer, Steffen, Thomas Müntefering, Leoni Rolfes, et al.. (2022). Deficiency of the Two-Pore Potassium Channel KCNK9 Impairs Intestinal Epithelial Cell Survival and Aggravates Dextran Sodium Sulfate-Induced Colitis. Cellular and Molecular Gastroenterology and Hepatology. 14(6). 1199–1211. 2 indexed citations
9.
Füting, Anna, et al.. (2022). Radiofrequency Pulmonary Vein Isolation without Esophageal Temperature Monitoring: Contact-Force Characteristics and Incidence of Esophageal Thermal Damage. Journal of Clinical Medicine. 11(23). 6917–6917. 2 indexed citations
10.
Vucur, Mihael, Ahmed Ghallab, Anne Schneider, et al.. (2022). Reprogramming necroptosis limits immune responses and prevents liver cancer development. Journal of Hepatology. 77. S11–S12. 1 indexed citations
11.
Bode, Johannes G., Björn‐Erik Ole Jensen, Jan Köhler, et al.. (2022). Improvement of liver-stiffness after 6 months of therapy: real-life data for HBV/HDV co-infected patients treated with bulevirtide. Journal of Hepatology. 77. S825–S825. 2 indexed citations
12.
Detjen, Katharina, Lukas Geisler, Pamela Riemer, et al.. (2021). Elevated Flt3L Predicts Long-Term Survival in Patients with High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms. Cancers. 13(17). 4463–4463. 6 indexed citations
13.
Kunstein, Anselm, et al.. (2021). Oro- und nasopharyngealer Abstrich – Schritt für Schritt. DMW - Deutsche Medizinische Wochenschrift. 146(6). 419–424. 1 indexed citations
14.
Bednarsch, Jan, Zoltán Czigány, Isabella Lurje, et al.. (2020). Intraoperative Transfusion of Fresh Frozen Plasma Predicts Morbidity Following Partial Liver Resection for Hepatocellular Carcinoma. Journal of Gastrointestinal Surgery. 25(5). 1212–1223. 11 indexed citations
15.
Tacke, Frank, Marcel Binnebösel, Christian Klink, et al.. (2018). Soluble urokinase plasminogen activator receptor (suPAR) represents a novel serum biomarker for patients undergoing resection of colorectal liver metastases. Journal of Hepatology. 68. S207–S207. 1 indexed citations
16.
Bartneck, Matthias, Thomas Ritz, Heidrun A. Keul, et al.. (2012). Peptide-Functionalized Gold Nanorods Increase Liver Injury in Hepatitis. ACS Nano. 6(10). 8767–8777. 136 indexed citations
17.
Sunami, Yoshiaki, Frank Leithäuser, Sarah Gul, et al.. (2012). 399 HEPATIC ACTIVATION OF IKK/NF-KB SIGNALING INDUCES LIVER FIBROSIS VIA MACROPHAGE-MEDIATED CHRONIC INFLAMMATION. Journal of Hepatology. 56. S160–S160. 4 indexed citations
18.
Beraza, Naiara, Tom Lüdde, Ulrike Assmus, et al.. (2007). Hepatocyte-Specific IKKγ/NEMO Expression Determines the Degree of Liver Injury. Gastroenterology. 132(7). 2504–2517. 66 indexed citations
19.
Lüdde, Tom, et al.. (2001). Ras adenoviruses modulate cyclin E protein expression and DNA synthesis after partial hepatectomy. Oncogene. 20(38). 5264–5278. 22 indexed citations
20.
Lüdde, Tom, et al.. (2000). Cyclin e is the primary target of activated ras in regeneratinghepatocyte and is regulated by post-transcriptional mechanisms. Journal of Hepatology. 32. 75–75. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria F. Leite Breakdown of academic impact, for papers by Lei Dou Breakdown of academic impact, for papers by Yaowei Bai Breakdown of academic impact, for papers by Chen Shen Breakdown of academic impact, for papers by Zhongqi Fan Breakdown of academic impact, for papers by Jessica Brownell Breakdown of academic impact, for papers by Zuojin Liu Breakdown of academic impact, for papers by Flaviana Cau Breakdown of academic impact, for papers by Feng Shen Breakdown of academic impact, for papers by Änne Schmitz
Rankless by CCL
2026